Intrinsic Value
TScan Therapeutics, Inc. (TCRX)
$7.29
-0.09 (-1.22%)
| Enterprise Value | - |
|---|---|
| Net Debt | -40.93 |
| Equity Value | - |
| Shares Outstanding | 65.60 |
| Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt